semaglutide mash pdufa Emerging Role of GLP-1 Receptor Agonists for the Treatment of Novo's Wegovy becomes first GLP-1

Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study

However, that does not automatically make it the better choice for every individual

on the other hand, injectable is required only once a week

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: an indirect treatment comparison

Combined SGLT2i and GLP-1RA therapy addresses multiple risk domains through complementary mechanisms and may be most effective within a phenotype-guided framework

It should only be considered after other factors (sleep, stress, dietary drift, exercise changes) have been evaluated and addressed